January 1, 2011Cardiology Research and PracticeOpen Access

Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers

View Full Paper

Ask AI

Bookmark

Population

Cancer patients receiving vascular endothelial growth factor (VEGF) inhibitors

Design

Review

Authors

CECarmen P. EscalanteThe University of Texas Rio Grande Valley AZAli ZalpourThe University of Texas MD Anderson Cancer Center

Discussion

Member takes

Implication

May inform PCP management of VEGF inhibitor hypertension; leaves open prospective trials to validate strategies.

Structured PICO

Population

Cancer patients receiving vascular endothelial growth factor (VEGF) inhibitors

Intervention

Vascular endothelial growth factor (VEGF) inhibitors

Outcome

Hypertensionsafety

This review provides primary care providers with essential knowledge on the mechanisms, diagnosis, and management of VEGF inhibitor-induced hypertension to prevent severe outcomes.

Cite This Study

Escalante et al. (2011) studied this question.

synapsesocial.com/papers/6a83ba97e0ccb21b1e8dcaba https://doi.org/10.4061/2011/816897

View Full Paper

Ask AI

Bookmark

Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider